A multicenter, prospective, randomized study to evaluate effects of targeting higher versus lower vancomycin trough levels on clinical outcomes of methicillin-resistant Staphylococcus aureus bacteraemia

Trial Profile

A multicenter, prospective, randomized study to evaluate effects of targeting higher versus lower vancomycin trough levels on clinical outcomes of methicillin-resistant Staphylococcus aureus bacteraemia

Completed
Phase of Trial: Phase II

Latest Information Update: 18 May 2016

At a glance

  • Drugs Vancomycin (Primary)
  • Indications Gram-positive infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 May 2016 New trial record
    • 12 Apr 2016 Results presented at the 26th European Congress of Clinical Microbiology and Infectious Diseases
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top